Tilray
TLRY
#6243
Rank
โ‚น76.59 B
Marketcap
โ‚น660.30
Share price
1.80%
Change (1 day)
509.29%
Change (1 year)

Revenue for Tilray (TLRY)

Revenue in 2025 (TTM): โ‚น71.73 Billion

According to Tilray 's latest financial reports the company's current revenue (TTM ) is โ‚น74.63 Billion. In 2024 the company made a revenue of โ‚น71.13 Billion an increase over the revenue in the year 2023 that were of โ‚น58.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tilray from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น71.73 B0.84%
2024 โ‚น71.13 B21.98%
2023 โ‚น58.31 B16.96%
2022 โ‚น49.86 B
2020 โ‚น25.05 B40.51%
2019 โ‚น17.83 B661.74%
2018 โ‚น2.34 B145.4%
2017 โ‚น0.95 B62.14%
2016 โ‚น0.58 B334.77%
2015 โ‚น0.13 B
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.3 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.68 B-22.71%๐Ÿ‡บ๐Ÿ‡ธ USA